Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026
Last 12 months price action with 12-month analyst target path
As of March 2, 2026, Alkermes plc (ALKS) has a Wall Street consensus price target of $46.00, based on estimates from 28 covering analysts. With the stock currently trading at $30.10, this represents a potential upside of +52.8%. The company has a market capitalization of $4.98B.
Analyst price targets range from a low of $43.00 to a high of $56.00, representing a 28% spread in expectations. The median target of $45.00 aligns closely with the consensus average.
The current analyst consensus rating is Buy, with 15 analysts rating the stock as a Buy or Strong Buy,11 rating it Hold, and 2 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, ALKS trades at a trailing P/E of 21.0x and forward P/E of 32.0x. Analysts expect EPS to grow -34.4% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $37.54, with bear and bull scenarios of $-186.69 and $438.24 respectively. Model confidence stands at 37/100, suggesting limited visibility into future performance.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how ALKS stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonThe consensus Wall Street price target for ALKS is $46, representing 52.8% upside from the current price of $30.1. With 28 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
ALKS has a consensus rating of "Buy" based on 28 Wall Street analysts. The rating breakdown is predominantly bullish, with 15 Buy/Strong Buy ratings. The consensus 12-month price target of $46 implies 52.8% upside from current levels.
ALKS trades at a forward P/E of 32.0417x, representing a moderate valuation. With analysts targeting $46 (52.8% implied move), the stock appears reasonably valued with upside.
The most bullish Wall Street analyst has a price target of $56 for ALKS, while the most conservative target is $43. The consensus of $46 represents the median expectation. Our quantitative valuation model projects a bull case target of $438 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
ALKS is heavily covered by Wall Street, with 28 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 15 have Buy ratings, 11 recommend Hold, and 2 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month ALKS stock forecast based on 28 Wall Street analysts shows a consensus price target of $46, with estimates ranging from $43 (bear case) to $56 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $38, with bear/bull scenarios of $-187/$438.
Our quantitative valuation model calculates ALKS's fair value at $38 (base case), with a bear case of $-187 and bull case of $438. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 37/100.
ALKS trades at a forward P/E ratio of 32.0x based on next-twelve-months earnings estimates compared to a trailing P/E of 21.0x. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on ALKS, with a "Buy" consensus rating and $46 price target (52.8% upside). 15 of 28 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
ALKS analyst price targets range from $43 to $56, a 28% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $46 consensus represents the middle ground. Our model's $-187-$438 range provides an independent fundamental perspective.